Guidelines for Scientific Exercise Therapy for People with Spinal Cord Injury

JRCT ID: jRCT1050220138

Registered date:23/12/2022

Basic Information

• Recruitment status: Pending
• Health condition(s) or Problem(s) studied: spinal cord injury
• Date of first enrollment: 23/12/2022
• Target sample size: 60
• Countries of recruitment: indonesia,Japan,Thailand,Japan
• Study type: Interventional

Intervention(s)

Exercise at home for 12 weeks
Aerobic exercise and strength training at least twice a week
Aerocic exercise
At leaset 20 minutes per session, moderate to intense intensity
Strength exercise
3 sets per session, moderate to intese intensity

Outcome(s)

• Primary Outcome: Maximal oxygen uptake and upper limb muscle strength (grip strength)
• Secondary Outcome: Body composition (muscle and fat mass), blood biochemistry test results (blood sugar, lipids, liver and kidney function), activity level

Key inclusion & exclusion criteria

• Age minimum: >= 18age old
• Age maximum: < 65age old
• Gender: Both

Include criteria

Adults with spinal cord injury in the chronic phase (at least one year after onset, neurological injury level C3 or less) due to traumatic or non-traumatic causes, including quadriplegia and paraplegia (as indicated in the guidelines)
Adults with spinal cord injury who are outpatients, living at home and have no exercise routine (to test effectiveness and feasibility).

Exclude criteria

... persons with cervical spinal cord injury (with upper limb paralysis and difficulty performing voluntary exercise therapy in Japan).
Spinal cord injury victims less than 12 months after the onset of the injury.
... older people aged 65 and over.
Persons with comorbidities such as cognitive impairment and mental disorders
People with chronic diseases for whom it is not appropriate to exercise (e.g. patients with severe blood pressure fluctuations).
... patients with inadequate measurement of maximal oxygen uptake (in the endpoints).
(Guidelines may be appropriate for people with spinal cord injury less than 12 months after onset, older than 65 years, or with comorbidities, but there is currently insufficient scientific evidence to draw firm conclusions about the risks and benefits of the guidelines for these individuals.)

Related Information

• Primary Sponsor: Umemoto Yasunori